Both groups of patients were evaluated for the occurrence of adverse reactions after the end of each treatment cycle, and their efficacy was evaluated after the end of every two treatment cycles
Both groups of patients evaluated the occurrence of adverse reactions at the end of each treatment cycle, and their efficacy was evaluated at the end of each of the two treatment cycles
The adverse reactions of the two groups were evaluated at the end of each treatment cycle, and their efficacy was evaluated at the end of each two treatment cycles<br>